Apolipoprotein E ε4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals

International Journal of Geriatric Psychiatry

Volumn 17, Issue 7, 2002, Pages 635-640

  Kim, K W ^a,b   Youn, J C ^b,e   Jhoo, J H ^b,c   Lee, D Y ^a,b   Lee, K U ^d   Lee, J H ^d   Woo, J I ^b,e  

^a Kyunggi Provincial Hospital for Elderly   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Anyang Metro Hospital   (South Korea)

^d Kangwon National University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

Age; Apolipoprotein E (APOE) 4; Cognitive; Gender; Normal elderly; Risk

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; DNA; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

AGE; AGED; AGING; ALLELE; ARTICLE; COGNITION; COGNITIVE DEFECT; COMMUNITY; COMPARATIVE STUDY; COVARIANCE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TASK PERFORMANCE; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDY; GENETICS; KOREA;

AGED; AGING; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KOREA; MALE; RISK FACTORS;

EID: 0035983305     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.664     Document Type: Article

References (23)

1. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: A review
2. Episodic memory changes are associated with the APOE ε4 allele in nondemented older adults
3. APOE ε4 is associated with memory decline in cognitively impaired elderly
4. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
5. Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery
6. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia
7. The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons
8. Sex differences in episodic memory: The impact of verbal and visuospatial ability
9. Age differences in fluid and crystallized intelligence
10. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease
11. Cerebrovascular disease, the apolipoprotein ε4 allele, and cognitive decline in a community-based study of elderly men
12. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans
13. The Domain-specific, stage-limited impact of the apolipoprotein E ε4 allele on cognitive functions in Alzheimer's disease
14. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Assessment Packet (CERAD-K). 2002. Clinical and neuropsychological assessment batteries
15. The APOE ε4 allele is associated with decline on delayed recall performance in community- dwelling older adults
16. Memory systems in normal and pathological aging
17. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E
18. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging
19. Pathological verification of ischemic score in differentiation of dementias
20. Is APOE ε4 a risk factor for cognitive impairment in normal aging?
21. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects
22. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
23. Heterogneity of cognitive profiles in aging: Successful aging, normal aging, and individuals at risk for cognitive decline